E. Akun Et Al. , "Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer," JOURNAL OF BUON , vol.17, no.4, pp.669-676, 2012
Akun, E. Et Al. 2012. Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer. JOURNAL OF BUON , vol.17, no.4 , 669-676.
Akun, E., Okutur, K., Seber, S., Korkmaz, T., Aydin, K., Bozkurt, M., ... Namal, E.(2012). Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer. JOURNAL OF BUON , vol.17, no.4, 669-676.
Akun, E. Et Al. "Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer," JOURNAL OF BUON , vol.17, no.4, 669-676, 2012
Akun, E. Et Al. "Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer." JOURNAL OF BUON , vol.17, no.4, pp.669-676, 2012
Akun, E. Et Al. (2012) . "Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer." JOURNAL OF BUON , vol.17, no.4, pp.669-676.
@article{article, author={E. Akun Et Al. }, title={Safety and tolerability of first-line bevacizumab in metastatic colorectal cancer}, journal={JOURNAL OF BUON}, year=2012, pages={669-676} }